Delpor
Delpor is a clinical stage biopharmaceutical company that utilizes innovative technologies to develop once-yearly therapeutics for chronic conditions. The Company's lead product is a 6-12-month formulation of Risperidone for the treatment of schizophrenia. Delpor is also pursuing 6-12-month formulations of other drugs targeting CNS conditions including schizophrenia, addiction, spasticity, Parkinson's, Alzheimer's, and other conditions.
Last updated on